Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
92 | Adverse Drug Reaction Bulletin | journal | 0.101 Q4 | 8 | 6 | 18 | 222 | 1 | 18 | 0.00 | 37.00 | |
91 | 2009 IEEE 3rd International Conference on Nano/Molecular Medicine and Engineering, NANOMED 2009 | conference and proceedings | 0.104 | 6 | 0 | 70 | 0 | 7 | 69 | 0.00 | 0.00 | |
90 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.107 Q4 | 40 | 0 | 6 | 0 | 1 | 6 | 0.00 | 0.00 | |
89 | Pharmacy Times | trade journal | 0.111 Q4 | 8 | 320 | 596 | 1222 | 14 | 485 | 0.03 | 3.82 | |
88 | Drug Topics | journal | 0.112 Q4 | 8 | 230 | 645 | 274 | 8 | 158 | 0.01 | 1.19 | |
87 | U.S. Pharmacist | trade journal | 0.113 Q4 | 12 | 158 | 435 | 2469 | 32 | 381 | 0.08 | 15.63 | |
86 | Psychopharm Review | trade journal | 0.122 Q4 | 5 | 12 | 36 | 420 | 11 | 36 | 0.33 | 35.00 | |
85 | 2010 IEEE International Conference on Nano/Molecular Medicine and Engineering, IEEE NANOMED 2010 | conference and proceedings | 0.130 | 5 | 0 | 53 | 0 | 15 | 50 | 0.28 | 0.00 | |
84 | Pharmaceutical Reviews | journal | 0.132 Q4 | 6 | 0 | 57 | 0 | 22 | 57 | 0.28 | 0.00 | |
83 | Proceedings of the Western Pharmacology Society | journal | 0.139 Q4 | 25 | 0 | 72 | 0 | 22 | 72 | 0.11 | 0.00 | |
82 | Hospital Pharmacy | journal | 0.141 Q4 | 28 | 132 | 465 | 1684 | 62 | 387 | 0.11 | 12.76 | |
81 | Pharmaceutical Chemistry Journal | journal | 0.147 Q4 | 39 | 162 | 452 | 2606 | 102 | 406 | 0.21 | 16.09 | |
80 | Journal of Applied Research | journal | 0.153 Q4 | 23 | 13 | 48 | 366 | 24 | 45 | 0.52 | 28.15 | |
79 | Clinical Research and Regulatory Affairs | journal | 0.156 Q4 | 18 | 11 | 45 | 155 | 11 | 41 | 0.18 | 14.09 | |
78 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.161 Q4 | 34 | 31 | 90 | 998 | 34 | 90 | 0.30 | 32.19 | |
77 | Food and Drug Law Journal | journal | 0.173 Q4 | 23 | 23 | 92 | 4024 | 39 | 91 | 0.28 | 174.96 | |
76 | Internet Journal of Pharmacology | journal | 0.176 Q3 | 9 | 0 | 71 | 0 | 40 | 71 | 0.47 | 0.00 | |
75 | National Toxicology Program technical report series | journal | 0.180 | 22 | 7 | 23 | 0 | 23 | 23 | 0.90 | 0.00 | |
74 | Cancer Therapy | journal | 0.184 Q3 | 9 | 2 | 68 | 74 | 32 | 68 | 0.10 | 37.00 | |
73 | Current Therapeutic Research | journal | 0.194 Q3 | 46 | 18 | 100 | 510 | 61 | 96 | 0.58 | 28.33 | |
72 | Medical Letter on Drugs and Therapeutics | journal | 0.199 Q3 | 22 | 139 | 381 | 531 | 109 | 334 | 0.32 | 3.82 | |
71 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.202 Q3 | 29 | 13 | 26 | 845 | 8 | 0 | 0.33 | 65.00 | |
70 | Current Cardiovascular Risk Reports | journal | 0.285 Q3 | 34 | 75 | 203 | 4704 | 107 | 201 | 0.60 | 62.72 | |
69 | Pharmacopeial Forum (discontinued) | journal | 0.294 Q3 | 20 | 11 | 66 | 62 | 44 | 47 | 0.26 | 5.64 | |
68 | Current Protocols in Pharmacology | journal | 0.301 Q3 | 39 | 19 | 58 | 653 | 38 | 54 | 0.55 | 34.37 | |
67 | International Journal of Medicinal Mushrooms | journal | 0.318 Q3 | 41 | 54 | 149 | 2199 | 150 | 148 | 0.90 | 40.72 | |
66 | Drug and Chemical Toxicology | journal | 0.390 Q3 | 54 | 70 | 173 | 2484 | 234 | 173 | 1.47 | 35.49 | |
65 | Journal of Experimental Therapeutics and Oncology | journal | 0.435 Q3 | 40 | 26 | 64 | 1153 | 99 | 61 | 1.15 | 44.35 | |
64 | Natural Product Communications | journal | 0.449 Q3 | 63 | 437 | 1197 | 10309 | 1520 | 1166 | 1.15 | 23.59 | |
63 | Biologicals | journal | 0.460 Q3 | 66 | 83 | 257 | 2297 | 503 | 245 | 1.95 | 27.67 | |
62 | American Journal of Therapeutics | journal | 0.468 Q3 | 69 | 101 | 344 | 3395 | 487 | 318 | 1.32 | 33.61 | |
61 | Journal of AOAC International | journal | 0.540 Q2 | 100 | 231 | 703 | 6760 | 1028 | 680 | 1.36 | 29.26 | |
60 | Journal of the American Pharmacists Association : JAPhA | journal | 0.589 Q2 | 73 | 146 | 386 | 2963 | 488 | 350 | 0.92 | 20.29 | |
59 | Reading Teacher | journal | 0.591 Q2 | 60 | 80 | 254 | 1578 | 201 | 237 | 0.49 | 19.73 | |
58 | Canadian Journal of Physiology and Pharmacology | journal | 0.648 Q2 | 95 | 173 | 382 | 8614 | 796 | 374 | 1.88 | 49.79 | |
57 | Chirality | journal | 0.656 Q2 | 83 | 141 | 435 | 5579 | 1083 | 432 | 2.21 | 39.57 | |
56 | Metal-Based Drugs | journal | 0.684 Q2 | 40 | 0 | 8 | 0 | 27 | 8 | 4.00 | 0.00 | |
55 | Basic and Clinical Pharmacology and Toxicology | journal | 0.691 Q2 | 103 | 144 | 410 | 5684 | 1002 | 400 | 2.41 | 39.47 | |
54 | American Journal of Health-System Pharmacy | journal | 0.700 Q2 | 107 | 362 | 1154 | 4867 | 1560 | 674 | 1.15 | 13.44 | |
53 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.756 Q2 | 68 | 93 | 267 | 3431 | 591 | 256 | 2.01 | 36.89 | |
52 | Journal of Ocular Pharmacology and Therapeutics | journal | 0.785 Q2 | 72 | 109 | 280 | 2867 | 566 | 272 | 1.89 | 26.30 | |
51 | Journal of Biopharmaceutical Statistics | journal | 0.793 Q2 | 56 | 81 | 246 | 1510 | 265 | 221 | 0.81 | 18.64 | |
50 | Journal of Pharmacy and Pharmaceutical Sciences | journal | 0.793 Q2 | 88 | 46 | 127 | 2461 | 352 | 124 | 2.71 | 53.50 | |
49 | Clinical Neuropharmacology | journal | 0.800 Q2 | 85 | 63 | 234 | 1632 | 611 | 208 | 2.52 | 25.90 | |
48 | Drug Development and Industrial Pharmacy | journal | 0.804 Q2 | 100 | 165 | 497 | 6188 | 994 | 496 | 1.93 | 37.50 | |
47 | Therapeutic Drug Monitoring | journal | 0.819 Q2 | 102 | 130 | 332 | 5643 | 1007 | 320 | 2.75 | 43.41 | |
46 | Journal of Pharmacological and Toxicological Methods | journal | 0.886 Q2 | 83 | 52 | 211 | 1798 | 478 | 205 | 2.24 | 34.58 | |
45 | Steroids | journal | 0.898 Q2 | 114 | 201 | 510 | 8821 | 1556 | 505 | 3.07 | 43.89 | |
44 | Anti-Cancer Drugs | journal | 0.936 Q2 | 102 | 136 | 391 | 5235 | 1230 | 383 | 2.81 | 38.49 | |
43 | Bulletin of Mathematical Biology | journal | 0.951 Q2 | 97 | 123 | 304 | 4877 | 671 | 301 | 2.15 | 39.65 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®